Latest Breaking News On - Purdue institute of inflammation - Page 6 : vimarsana.com
What we know and don t know about the new UK COVID-19 variant - Health News
abcnewsradioonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from abcnewsradioonline.com Daily Mail and Mail on Sunday newspapers.
What we know and don t know about the new UK COVID-19 variant
940wfaw.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 940wfaw.com Daily Mail and Mail on Sunday newspapers.
Here s everything we know and don t know about the new UK COVID-19 variant
⢠6 min read
Britain in lockdown, travel bans after COVID-19 mutation
The mutation is potentially more contagious and is spreading rapidly in the U.K. There is no hard evidence that this variant is more contagious, and scientists said more studies are needed.Tolga Akmen/WPA Pool/Getty Images
With news of a mutant COVID-19 virus dominating headlines, scientists, doctors and virologists say itâs too soon to panic about the potential implications of the new variant identified in the United Kingdom.
This isnât the first time the SARS-2 virus has mutated developing small errors that show up and become integrated into its genetic code. And it wonât be the last. But so far, none of those prior mutations have had a major impact when it comes to the severity of the illness, or crucially when it comes to the vaccine.
Justin Tallis/Getty Images
Thousands of vials of the newly approved Pfizer-BioNtech coronavirus vaccine began arriving in all 50 states on Monday, and about 2.9 million doses are expected to be distributed over this week.
A nurse in New York City was one of the first Americans to receive an initial dose of the COVID-19 vaccine Monday morning, according to USA Today. I feel hopeful today, said Sandra Lindsay, a critical care nurse at New York s Long Island Jewish Medical Center, after she received the shot.
Healthcare workers and residents of long-term care facilities are prioritized to be inoculated first, in accordance with a recommendation made at the beginning of the month by the Centers for Disease Control and Prevention (CDC).
Key Takeaways
The vaccines showing the most promise are a new type, known as messenger RNA (mRNA) vaccines.
Before COVID-19, mRNA vaccines were never on the market, but they have been studied.Welcome back to
Track the Vax, a weekly podcast from Everyday Health and MedPage Today, where we speak with leading experts, pharmaceutical companies, and physicians and patients on the latest news and science behind the race for a COVID-19 vaccine.
This week, we talk to Richard Kuhn, PhD, a professor of science at Purdue University in West Lafayette, Indiana, and the editor in chief of the journal
Virology.
vimarsana © 2020. All Rights Reserved.